Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biodelivery Sci Intl (BDSI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 260,920
  • Shares Outstanding, K 70,710
  • Annual Sales, $ 61,990 K
  • Annual Income, $ 5,290 K
  • 36-Month Beta 0.12
  • Price/Sales 4.07
  • Price/Cash Flow N/A
  • Price/Book 5.98

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.11
  • Number of Estimates 3
  • High Estimate -0.10
  • Low Estimate -0.12
  • Prior Year -0.29
  • Growth Rate Est. (year over year) +62.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.43 +2.92%
on 11/29/18
3.94 -10.41%
on 12/06/18
-0.05 (-1.40%)
since 11/14/18
3-Month
2.55 +38.43%
on 09/19/18
4.14 -14.73%
on 11/02/18
+0.73 (+26.07%)
since 09/14/18
52-Week
1.70 +107.65%
on 05/11/18
4.14 -14.73%
on 11/02/18
+0.90 (+34.48%)
since 12/14/17

Most Recent Stories

More News
Antares Pharma Announces the Appointment of Peter S. Greenleaf to Company's Board of Directors

Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of Peter S. Greenleaf to the Company's Board of Directors. Mr. Greenleaf has over 20 years of biopharmaceutical experience, and currently...

BDSI : 3.55 (-3.79%)
ATRS : 3.02 (-2.89%)
CERC : 3.32 (-2.35%)
Avadel Pharmaceuticals Appoints Kevin Kotler to the Company's Board of Directors

Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on providing innovative medicines for chronic urological, central nervous system, and sleep disorders, today announced that Kevin Kotler, the...

AVDL : 2.45 (-9.26%)
BDSI : 3.55 (-3.79%)
BioDelivery (BDSI) Down 1.6% Since Last Earnings Report: Can It Rebound?

BioDelivery (BDSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BDSI : 3.55 (-3.79%)
BioDelivery (BDSI) Q3 Earnings Beat, Sales In Line, Stock Up

BioDelivery Sciences (BDSI) reports narrower-than-expected loss in Q3. Sales were almost in line with the consensus mark.

ESRX : 98.22 (-0.74%)
ENDP : 10.19 (-8.53%)
BDSI : 3.55 (-3.79%)
TEVA : 18.46 (-2.94%)
Consolidated Research: 2018 Summary Expectations for Murphy Oil, REGENXBIO, CRA International,Inc, Carriage Services, CONMED, and BioDelivery Sciences International -- Fundamental Analysis, Key Performance Indications

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Murphy Oil Corporation (NYSE:MUR),...

CSV : 15.47 (-1.90%)
BDSI : 3.55 (-3.79%)
CRAI : 44.49 (-3.28%)
RGNX : 45.72 (-0.67%)
MUR : 27.54 (-3.61%)
CNMD : 63.74 (-5.33%)
BioDelivery Sciences International (BDSI) Reports Q3 Loss, Misses Revenue Estimates

BioDelivery (BDSI) delivered earnings and revenue surprises of 28.57% and -0.38%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

BDSI : 3.55 (-3.79%)
BioDelivery Sciences Reports Strong Third Quarter 2018 Financial Results

-- BELBUCA continued on an accelerated growth trajectory, with revenue increasing 92% YOY and 27% versus prior quarter

BDSI : 3.55 (-3.79%)
Is a Beat in Store for Humana (HUM) Stock in Q3 Earnings?

Humana's (HUM) Q3 is likely to gain from solid segmental performances and higher enrollment.

EYE : 29.84 (-2.77%)
HUM : 300.28 (-3.91%)
CRSP : 32.69 (-2.24%)
BDSI : 3.55 (-3.79%)
5 Drug/Biotech Stocks Set to Trump Estimates in Q3 Earnings

There are still a number of drug/biotech companies poised to surpass third-quarter estimates.

CRSP : 32.69 (-2.24%)
BDSI : 3.55 (-3.79%)
EDIT : 28.45 (-1.69%)
REGN : 381.17 (+0.70%)
MACK : 4.08 (+1.75%)
BioDelivery Sciences Announces Further Significant Expanded Preferred Coverage For BELBUCA(R)

More than 100 million Covered Lives Now Have Preferred Access to BELBUCA

BDSI : 3.55 (-3.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade BDSI with:

Business Summary

BioDelivery Sciences International is a development-stage biotechnology company that is developing and seeking to commercialize a drug delivery technology designed for a potentially broad base of pharmaceuticals, vaccines and over-the-counter drugs. In general, a drug delivery technology refers to any...

See More

Key Turning Points

2nd Resistance Point 3.91
1st Resistance Point 3.80
Last Price 3.55
1st Support Level 3.55
2nd Support Level 3.41

See More

52-Week High 4.14
Last Price 3.55
Fibonacci 61.8% 3.21
Fibonacci 50% 2.92
Fibonacci 38.2% 2.63
52-Week Low 1.70

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar